Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia
El-Sayed, M., Mohamed, M. (2021). Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia. EKB Journal Management System, 6(2), 293-296. doi: 10.21608/bjas.2021.169466
M.A. El-Sayed; M.A. Mohamed. "Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia". EKB Journal Management System, 6, 2, 2021, 293-296. doi: 10.21608/bjas.2021.169466
El-Sayed, M., Mohamed, M. (2021). 'Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia', EKB Journal Management System, 6(2), pp. 293-296. doi: 10.21608/bjas.2021.169466
El-Sayed, M., Mohamed, M. Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia. EKB Journal Management System, 2021; 6(2): 293-296. doi: 10.21608/bjas.2021.169466

Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia

Benha Journal of Applied Sciences
Article 46, Volume 6, Issue 2, March and April 2021, Page 293-296  XML PDF (412.48 K)
Document Type: Original Research Papers
DOI: 10.21608/bjas.2021.169466
View on SCiNiTO View on SCiNiTO
Authors
M.A. El-Sayed; M.A. Mohamed
Urology , Dept., Faculty of Medicine, Benha Univ., Benha, Egypt
Abstract
Foundation: Lower urinary plot side effects (LUTS) related with benevolent prostatic hyperplasia (BPH) and erectile brokenness (ED) are basic problems whose pervasiveness increments with propelling age We expected to think about between viability of tadalafil 5 mg and tamsulosin 0.4mg monotherapy versus joined treatment in treatment of lower urinary parcel indications of generous prostatic hyperplasia. Patient and techniques: This randomized, single-daze, resembled bunch clinical preliminary was done on 60 patients with ED and LUTS because of BPH were remembered for an imminent report and Received treatment. Gathering A got 5 mg/day by day tadalafil; Group B got 0.4 mg/day by day tamsulosin; Group C receieved a blend of 0.4 mg/day by day tamsulosin and 5 mg/day by day tadalafil.          The three gatherings were been contrasted concurring with International prostate indication score (IPSS), International file of erectile brokenness (IIEF) score and maximal urinary stream rate (Qmax) Results: Post-void remaining level was essentially extraordinary when the treatment, aside from bunch A. Additionally, this gathering had no significant distinction contrasted with different gatherings in such manner (P > 0.05). There were huge contrasts among pre-and post-treatment global prostate side effect scores in each gathering (P < 0.05). End: blend treatment with tadalafil and tamsu-losin is suggested as a result of its great results in erectile brokenness.
Keywords
Tamsulosin; Tadalafil; Benign Prostatic Hyperplasia
Statistics
Article View: 135
PDF Download: 359